Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423470 · ClinicalTrials.gov registry record · NA
Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05423470 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 41 participants.
The verdict
NCT05423470, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that intermittent hypoxia will attenuate the reduction in flow-mediated dilation following ischemia-reperfusion injury.
Interventions
- BEHAVIORAL Intermittent hypoxia
- BEHAVIORAL Intermittent normoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05423470
The ClinicalTrials.gov registry entry for NCT05423470 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intermittent hypoxia is the first listed.
NCT05423470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05423470 about?
NCT05423470 is a clinical study titled "Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals". The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that intermittent hypoxia will attenuate the reduction in flow-mediated dilation following ischemia-reper...
What is the current status of trial NCT05423470?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-05-30. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT05423470?
The interventions under investigation include: Intermittent hypoxia (BEHAVIORAL), Intermittent normoxia (BEHAVIORAL).
Who is sponsoring clinical trial NCT05423470?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.